MB
Live price temporarily unavailable.
Price history
Mbx Biosciences Inc (MBX) is a Health Care company in the Russell 2000. Latest news and coverage below.
IPO: September 13, 2024 · $16.00 offering · NASDAQ · View IPO details →
Recent News (2)
-
MBX Biosciences doses first patient in phase 3 HP trial
MBX Biosciences doses first patient in phase 3 HP trial
-
MBX Biosciences Announces First Patient Dosed in Pivotal Phase 3 oPTimize Trial of Once-Weekly Canvuparatide in Adults with Hypoparathyroidism Pivotal Phase 3 oPTimize trial design builds on positive Phase 2 Avail™ results and durable one-year clinical benefit
More Health Care stocks
- AZN AstraZeneca
- ILMN Illumina
- A Agilent Technologies
- ABBV AbbVie
- ABT Abbott Laboratories
- ALGN Align Technology
- AMGN Amgen
- BAX Baxter International